Can a diet app help cancer patients recover? small study says maybe
NCT ID NCT05649969
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a 12-week program that gave nutrition counseling and a Fitbit app to 10 people with gastrointestinal cancer who had surgery and chemotherapy. The goal was to see if the program was easy to use and if patients liked it. Researchers measured how many people joined, stuck with it, and reported satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Nutrition counseling and dietary tracking via Fitbit app
- What this could lead to
- If successful, this program could help cancer patients manage nutrition better during treatment, potentially improving recovery and quality of life.
- What could go wrong
- This is a very small, early feasibility study with only 10 participants, so results may not apply to everyone. It does not test whether the program directly improves survival or disease outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
10 people
The number who actually took part.
- Started
-
Dec 2022
- Finished
-
Jan 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Gastrointestinal Cancer diagnosis (e.g., colon cancer, appendiceal cancer) * Peritoneal disease diagnosis * Received Cytoreductive Surgery and Heated Intra-Peritoneal Chemotherapy (CRS-HIPEC) for curative intent at Moffitt * Transitioned to an oral diet post-surgery * Able to speak and read English * Able to provide informed consent Exclusion Criteria: * Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse) * Undergoing concurrent treatment for a secondary primary cancer * Receipt of parenteral or enteral nutrition after surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastrointestinal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Muscle loss may predict who struggles after cancer surgery
- Can a simple frailty check predict who bounces back after cancer surgery?
- Can a 12-week exercise program fight cancer-related muscle wasting?
- Could patient tissue samples unlock new treatments for gut diseases?
- A future without surgery for stomach and colon cancers?
- Wearable tech could spot Post-Surgery problems early